Chlamydia trachomatis

Women and Health

Volumn , Issue , 2013, Pages 445-459

  Gaydos, Charlotte A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883955974     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-384978-6.00029-7     Document Type: Chapter

References (139)

1. Centers for Disease Control and Prevention Sexually transmitted disease surveillance, 2010 2010, US Department of Health and Human Services, Atlanta, GA, CDC 2011;1-155.
2. Miller W.C., Zenilman J.M. Epidemiology of chlamydial infection, gonorrhea, and trichomoniasis in the United States. Infect Dis Clin North Am 2005, 19:281-296.
3. Campbell L.A., Kuo C.-C., Gaydos C.A. Chlamydial infections. Manual of molecular and clinical laboratory immunology 2006, 518-525. ASM Press, Washington DC. 7th ed. B. Detrick, R.G. Hamilton, J.D. Folds (Eds.).
4. Gaydos C.A. Chlamydiae. Clinical virology manual 2009, 630-640. ASM Press, Washington, D.C. 4th ed. S. Spector, R.L. Hodinka, S.A. Young, D.L. Wiedbrauk (Eds.).
5. Gaydos C.A., Quinn T.C. Chlamydia infections. Harrison's principles of internal medicine 2011, 1421-1431. McGraw Hill Medical, New York. 18th ed. D. Longo, A.S. Fauci, D.L. Kasper, S.L. Hauser, J. Larry Jameson, J. Loscalzo (Eds.).
6. Stamm W.E. Chlamydia trachomatis infections of the adult. Sexually transmitted diseases 2008, 575-593. McGraw-Hill, New York. 4th ed. K.K. Holmes, P.F. Sparling, W.E. Stamm, P. Piot, J.N. Wasserheit, L. Corey (Eds.).
7. Centers for Disease Control and Prevention. Sexually transmitted disease treatment guidelines 2010. MMWR Dec 17, 2010; at CDC 2010;59: 1-110. http://www.cdc.gov/std/treatment/2010.
8. Hillis S.D., Joesoef R., Marchbanks P.A., Wasserheit J.N., Cates W., Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impared fertility. Am J Obstet Gynecol 1993, 168:1503-1509.
9. Hillis S.D., Wasserheit J.N. Screening for Chlamydia - a key to the prevention of pelvic inflammatory disease. N Engl J Med 1996, 334:1399-1401.
10. Hillis S.D., Owens L.M., Marchbanks P.A., Amsterdam L.F., MacKenzie W.R. Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 1997, 176:103-107.
11. Scholes D., Satterwhite C., Yu O., Fine D., Weinstock H., Berman S. Long-term trends in Chlamydia trachomatis infections and related outcomes in a US managed care population. Sex Transmit Dis 2012, 39:81-88.
12. Bohm M., Newman L., Satterwhite C., et al. Pelvic inflammatory disease among privately insured women, United States, 2001-200. Sex Transmit Dis 2010, 39:131-136.
13. US Preventive Services Task Force Screening for chlamydial infection: US preventive services task force recommendation statement. Ann Intern Med 2007, 147:128-134.
14. National committee for Quality Assurance. The State of Health Care Quality 2010: HEDIS Measures of Care, Washington, DC; 2010;43-4. http://www.ncqa.org/portals/0/state%020of%20health%20care/2010/SOHC%2020 10%20-%20Full2.pdf.
15. Gaydos C.A. Nucleic acid amplification tests for gonorrhea and chlamydia: practice and applications. Infect Dis Clin N Am 2005, 19(2):367-386.
16. Gaydos C.A., Quinn T.C., Willis D., Weissfeld A., Hook E.W., Martin D.H., et al. Performance of the APTIMA combo 2 assay for the multiplex detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol 2003, 41:304-309.
17. Gaydos C.A., Theodore M., Dalesio N., Wood B.J., Quinn T.C. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens. J Clin Microbiol 2004, 42:3041-3045.
18. Schachter J., Chernesky M.A., Willis D.E., Fine P.M., Martin D.H., Fuller D., et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transmit Dis 2005, 32:725-728.
19. Gaydos C.A. Sexually transmitted infections screening and diagnostic practices. Sexually transmitted infections 2011, 1242-1250. Elsevier, New Delhi, India. 2nd ed. B.K. Somesh Gupta (Ed.).
20. Shafer M.B., Pantell R.H., Schachter J. Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases?. Arch Pediatr Adolesc Med 1999, 153:119-125.
21. Gaydos C.A., Rompalo A.M. The use of urine and self-obtained vaginal swabs for the diagnosis of sexually transmitted diseases. Current Infect Dis Reports 2002, 4:148-157.
22. Schachter J., McCormick W.M., Chernesky M.A., Martin D.H., Van Der Pol B., Rice P., et al. Vaginal swabs are appropriate specimens for diagnosis of genital tract infection with Chlamydia trachomatis. J Clin Microbiol 2003, 41:3784-3789.
23. Weinstock H., Berman S., Cates W. Sexually transmitted disease among American youth: incidence and prevalence estimates. Perspect Sex Repro Health 2004, 36:6-10.
24. Datta S., Torrone E., Kruszon-Moran D., Berman S., Johnson R., Satterwhite C.L., et al. Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2998. Sex Transmit Dis 2012, 39:92-96.
25. Satterwhite C., Tian L.H., Braxton J., et al. Chlamydia prevalence among women and men entering the national job training program: United States, 2003-2007. Sex Transmit Dis 2010, 37:63-67.
26. Cecil J.A., Howell M.R., Tawes J.J., Gaydos J.C., McKee J.K.T., Quinn T.C., et al. Features of Chlamydia trachomatis and Neisseria gonorrhoeae infection in male army recruits. J Infect Dis 2001, 184:1216-1219.
27. Schillinger J.A., Chapman J.B., Rietmeijer C.A., Ellen J.M., Gaydos C.A., Willard N.J., et al. Prevalence of Chlamydia trachomatis infection among men screened in four US cities. Sex Transm Dis 2005, 32:74-77.
28. Haggerty C., Gottlieb S., Taylor B., et al. Risk of sequelas after Chlamydia trachomatis genital infection in women. J Infect Dis 2010, 201(Suppl. 2):S134-S155.
29. Fortenberry J., Brizendine E., Katz B., Wools K., Blythe M., Orr D. Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis. Sex Transmit Dis 1999, 26:32.
30. Hosenfield C., Workowski K., Berman S., et al. Repeat infection with Chlamydia trachomatis and gonorrhea among females: a systematic review of the literature. Sex Transmit Dis 2009, 36:478-489.
31. Batteiger B., Tu W., Ofner S., et al. Repeated Chlamydia trachomatis genital infections in adolescent women. J Infect Dis 2010, 201:42-51.
32. Gaydos C.A., Wright C., Wood B.J., Waterfield G., Hobson S., Quinn T.C. Chlamydia trachomatis reinfection rates among female adolescents seeking rescreening in school-based health centers. Sex Tansmit Dis 2008, 35:233-237.
33. Burstein G., Gaydos C.A., Diener-West M., Howell M.R., Zenilman J., Quinn T.C. Incident Chlamydia trachomatis infections among inner city adolescent females: implications for frequency of chlamydial screening. JAMA 1998, 280:521-526.
34. Guy R., Hocking J., Low N., Hammad A., Bauer H., Walker J., et al. Interventions to increase rescreening for repeat chlamydial infection. Sex Transmit Dis 2012, 39:136-146.
35. Cook R.L., Ostergaard L., Hillier S.L., Murray P.J., Chang C.C., Comer D.M., et al. Home screening for sexually transmitted diseases in high risk young women: randomized controlled trial. Sex Transm Inf 2007, 83:285-291.
36. Xu F., Stoner B., Taylor S.N., Mena L., Tian L.H., Papp J., et al. Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials. Obstet Gyneco 2011, 118:231-239.
37. Gaydos C.A., Dwyer K., Barnes M., Rizzo-Price P.A., Wood.B.J., Flemming T., et al. Internet based screening for Chlamydia trachomatis to reach non-clinic populations with mailed self-administered vaginal swabs. Sex Tansmit Dis 2006, 33:451-457.
38. Gaydos C.A., Barnes M., Aumakham B., Quinn N., Agreda P., Whittle P., et al. Can e-technology through the internet be used as a new tool to address the Chlamydia trachomatis epidemic by home samplng and vaginal swabs?. Sex Tansmit Dis 2009, 36:577-580.
39. Grasek A.A., Secura G.M., Allsworth J.E., Madden T., Peipert J.F. Home-screening compared with clinic-based screening for sexually transmitted infections. Obstet Gynecol 2010, 115:745-752.
40. Cohall A., Resnick M. Advances in health promotion for adolescents and young adults (Adolescent Medicine: State of the Art Reviews). American Academy of Pediatrics 2011.
41. Gaydos C.A., Howell M.R., Pare B., Clark K.L., Ellis D.A., Hendrix R.M., et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998, 339(11):739-744.
42. Gaydos C.A., Howell M.R., Quinn J.C., McKee J.K.T., Gaydos J.C. Sustained high prevalence of Chlamydia trachomatis infections in female army recruits. Sex Trans Dis 2003, 30:539-544.
43. Gaydos C.A. STI management and control in North America IUSTI region. Sex Transmit Dis 2011, (87 Suppl.):ii2-eii6. 10.1136/sextrans-2011-050287.
44. Miller W.C., Ford C.A., Morris M., Handcock M.S., Schmitz J.L., Hobbs M.M., et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004, 291:2229-2236.
45. Marrazzo J.M., White C.L., Krekeler B., Celum C.L., Lafferty W.E., Stamm W.E., et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 1997, 127:796-803.
46. Fine D., Thomas K., Nakatsukasa-Ono W., Marrazzo J. Chlamydia positivity in women screened in family planning clinics: racial/ethnic differences and trends in the northwest US, 1997-2006. Pub Health Rep 2012, 127:38-51.
47. Berman S., Ellen J. Adolescents and STDs including HIV infection. Sexually transmitted diseases 2008, 165-185. McGraw Hill Medical, New York. 4th ed. K.K. Holmes, P.F. Sparling, W.E. Stamm, P. Piot, J.N. Wasserheit, L. Corey (Eds.).
48. Brunham R.C., Pourbohloul B., Mak S., White R., Rekart M.L. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005, 192:1836-1844.
49. Batteinger B., Xu F., Johnson R., Rekart M.L. Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies. J Infect Dis 2010, 201(Suppl.):S178-S189.
50. Centers for Disease Control and Prevention Sexual behavior, sexual attraction, and sexual identity in the United States: data from the 2006-2008 national survey of family growth. National Health Statistics Reports 2011, 36.
51. Quinn T.C., Gaydos C., Shepherd M., Bobo L., Hook E.W., Viscidi R., et al. Epidemiological and microbiological correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996, 276:1737-1742.
52. Tu W., Ghosh P., Katz B.A. Stochastic model for assessing Chlamydia trachomatis transmission risk using longitudinal observational data. J R Stat Soc Ser A Stat Soc 2011, 174:975-989.
53. Gaydos C.A., Howell M.R., Quinn T.C., Gaydos J.C., McKee K.T. Use of ligase chain reaction with urine versus cervical culture for detection of Chlamydia trachomatis in an asymptomatic military population of pregnant and non-pregnant females attending Papanicolaou smear clinics. J Clin Microbiol 1998, 36:1300-1304.
54. Geisler W. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis 2010, 201(Suppl.):S104-S113.
55. Geisler W., Wang C., Morrison S., Black C., Bandea C., Hook E.W. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transmit Dis 2008, 35:119-123.
56. Molano M., Meijer C.J.L.M., Weiderpass E., Arslan A., Posso H., Franceschi S., et al. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 2005, 191:907-916.
57. Morre S., van den Brule A., Rozendaal L., et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up. Int J STD AIDS 2002, 13(Suppl.):12-18.
58. Rogers S., Miller W.C., Turner C. Concordance of Chlamydia trachomatis infections within sexual partnerships. Sex Transmit Infect 2008, 84:23-28.
59. Stergachis A., Scholes D., Heidrich F.E., Sherer D.M., Holmes K.K., Stamm W.E. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Amer J Epidemiol 1993, 138:143-153.
60. Howell M.R., Quinn T.C., Brathwaite W., Gaydos C.A. Screening women for Chlamydia trachomatis in family planning clinics: the cost-effectiveness of DNA amplification assays. Sex Transmit Dis 1998, 25(2):108-117.
61. Howell M.R., Quinn T.C., Gaydos C.A. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics: a cost effectiveness analysis of three preventive strategies. Ann Intern Med 1998, 128:277-284.
62. Howell M.R., Gaydos J.C., McKee J.K.T., Quinn T.C., Gaydos C.A. Control of Chlamydia trachomatis in female army recruits: cost-effective screening and treatment to prevent pelvic inflammatory disease. Sex Transmit Dis 1999, 26:519-526.
63. Washington A.E., Katz P. Cost of and payment source for pelvic inflammatory disease: trends and projections, 1983 through 2000. JAMA 1991, 266:2565-2569.
64. Gottlieb S., Berman S., Low N. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?. J Infect Dis 2010, 201(Suppl.):S156-S167.
65. Scholes D., Stergachis A., Heidrich F.E., Andrilla H., Holmes K.K., Stamm W.E. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996, 334:1362-1366.
66. Ostergaard L., Andersen B., Moller J.K., Olesen F. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Inf Dis 2000, 31:951-957.
67. Clark K.L., Howell R.M., Li Y., Powers T., MeKee K.T., Quinn T.C., et al. Hospitalization rates in female US army recruits associated with a screening program for C. trachomatis. Sex Transm Dis 2002, 29:1-5.
68. Low N., Egger M., Sterne J.A., et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala women's cohort study. Sex Transmit Infect 2006, 82:212-218.
69. Holmes K.K., Stamm W.E., Sobel J.D. Lower genital tract infection syndromes in women. Sexually transmitted diseases 2008, 987-1016. 4th ed. K.K. Holmes, P.F. Sparling, W.E. Stamm, P. Piot, J.N. Wasserheit, L. Corey (Eds.).
70. Burstein G., Gaydos C., Diener-West M., et al. Predictors of C. trachomatis infection by polymerase chain reaction among females presenting to US inner city clinics. Internat Congress Sex Transm Dis 1997, 195. 12th annual meeting Seville, Spain.
71. Critchlow C., Wolner-Hanssen P., Eschenbach D., et al. Determinants of cervical ectopia and of cervicitis: age, oral contraceptives, specific cervical infection, smoking and douching. Am J Obstet Gynecol 1995, 173:534-543.
72. Paavonen J., Westrom L., Eschenbach D. Pelvic inflammatory disease. Sexually transmitted diseases 2008, 1017-1050. McGraw Hill Medical, New York. 4th ed. K.K. Holmes, P.F. Sparling, W.E. Stamm, P. Piot, J.N. Wasserheit, L. Corey (Eds.).
73. Ness R.B., Randall H., Richter H.E., Peipert J.F., Montagno A., Soper D., et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Amer J of Public Health 2004, 94:1327-1329.
74. Centers for Disease Contol and Prevention. Pelvic inflammatory disease: guidelines for prevention and management. MMWR 1991;40 (RR-5):1-25.
75. Nelson D.B., Ness R.B., Peipert J.F., et al. Factors predicting upper genital tract inflammation amoung women with lower tract infection. J Womens Health 1998, 7:1033-1040.
76. Sellors J., Mahony J., Goldsmith C., et al. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. Am J Obstet Gynecol 1991, 164:113-120.
77. Yeh J.M., Hook E.W., Goldie S.J. A refined estimate of the average lifetime cost of pelvic inflammatory disease. Sex Transm Dis 2003, 30:369-378.
78. Rein D., Gift T. A refined estimate of the lifetime cost of pelvic inflammatory disease. Sex Transmit Dis 2004, 31:325.
79. CDC. Pregnancy-related mortality surveillance - United States, 1991-1999. MMWR 2003;52.
80. Creanga A., Shapiro-Mendoza C., Bish C., Zane S., Berg C., Callaghan W. Trends in ectopic pregnancy mortality in the United States 1980-2007. Obstet Gynecol 2011, 117:837-843.
81. Westrom L., Joesoef R., Reynolds G., Hagdu A., Thompson S.E. Pelvic inflammatory disease and fertility: a cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992, 152:1275-1282.
82. Westrom L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Amer J Obst Gyne 1980, 138:880-892.
83. Westrom L., Bengtsson L., Mardh P.-A. Incidence, trends, and risks of ectopic pregnancy in a population of women. Brit Med J 1981, 282:15-18.
84. Westrom L. Effect of pelvic inflammatory disease on fertility. Venereology 1995, 8:219-222.
85. Chow J.M., Yonekura L., Richwals G.A., Greenland S., Sweet R.L., Schachter J. The association between Chlamydia trachomatis and ectopic pregnancy, a matched-pair, case-control study. JAMA 1990, 263:3164-3167.
86. WHO Task Force on the Prevention and Management of Infertility Tubal infertility: serological relationship to past chlamydial and gonococcal infection. STD 1995, 22:71-77.
87. Kohlhoff S.A., Hammerschlag M. Gonococcal and chlamydial infections in infants and children. Sexually transmitted diseases 2008, 1613-1627. McGraw Hill, New York. 4th ed. K.K. Holmes, P.F. Sparling, W.E. Stamm, P. Piot, J.N. Wasserheit, L. Corey (Eds.).
88. Hammerschlag M. Infections due to Chlamydia and Chlamydia pneumoniae in children and adolescents. Pediatr Rev 2004, 25:43-51.
89. Wasserheit J.N. Epidemiological synergy: interrelationships between human immunodeficiency virus and other sexually transmitted diseases. Sex Transmit Dis 1992, 19:61-77.
90. Laga M., Manoka A., Kivuvu M., Malele B., Tuliza M., Nzilambi N., et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993, 7:95-102.
91. Laga M., Diallo M.O., Buve A. Inter-relationship of sexually transmitted diseases and HIV: where are we now?. AIDS 1994, 8:s119-s124.
92. Fleming D.T., Wasserheit J. From epidemiological synergy to public health policy and pratice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Inf 1999, 75:3-17.
93. Hughes J., Baeten J.M., Lingappa J.R., Magaret A.S., Wald A., de Bruyn G., et al. Determinants of per-coital act HIV-1 infectivity among African HIV-1-serodiscordant couples. J Infect Dis 2012, 205:358-365.
94. Gaydos C.A., Essig A. Chlamydiaceae. Manual of clinical microbiology 2011, 986-1000. American Society for Microbiology, Washington, DC. 10th ed. P.R. Murray, E. Jo Baron, J.H. Jorgensen, M. Louise Landry, M.A.P. Faller (Eds.).
95. Black C.M., Driebe E.M., Howard L.A., Fajman N.N., Sawyer M.K., Girardet R.G., et al. Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse. Pediatr Infect Dis J 2009, 28:608-613.
96. Kuypers J., Gaydos C.A., Peeling R.W. Principles of laboratory diagnosis of STIs. Sexually transmitted diseases 2008, 937-957. MeGraw Hill, New York. 4th ed. K.K. Holmes, P.F. Sparling, W.E. Stamm, P. Piot, J.N. Wasserheit, L. Corey (Eds.).
97. Gaydos C.A., Cartwight C.P., Colaninno P., Welsch J., Holden J., Ho S.Y., et al. Performance of the abbott realtime CT/NG for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2010, 48:3236-3243.
98. APHL/CDC Panel Summary Reports. Laboratory diagnostic testing for Chlamydia trachomatis and Neisseria gonorrhoeae, laboratory diagnostic testing for Treponema pallidum. Guidelines for the laboratory testing of STDs.2009 [accessed 2.02.2012]. http://www.aphl.org/aphlprograms/infectious/std/Pages/stdtestingguidelin es.aspx.
99. Schachter J. Chlamydia trachomatis: the more you look, the more you find - how much is there?. Sex Transmit Dis 1998, 25:229-231.
100. Yin Y.-P., Peeling R.W., Chen X.-S., Gong K.-L., Zhou H., Gu W.-P., et al. Clinic-based evaluation of clearview chamydia MF for detection of Chlamydia trachomatis in vaginal and cervical specimens from women at risk in China. Sex Transm Infect 2006, (82 suppl.):v33-v37.
101. Pearce D.M., Shenton D.P., Holden J., Gaydos C.A. Evaluation of a novel electrochemical detection method for Chlamydia trachomatis: application for point-of-care diagnostics. IEEE Trans BioMed Eng 2011, 58:755-758.
102. Zang Y., Agreda P., Kelly S., Gaydos C.A., Geddes C.D. Development of a microwave-accelerated metal-enhanced fluorescence 40 second, 100 cfu/mL point of care assay for the detection of Chlamydia trachomatis. IEEE Trans BioMed Eng 2011, 58:781-784.
103. Huppert J.S., Hesse E., Gaydos C.A. What's the point? How point-of-care sexually transmitted infection tests can impact infected patients. Point of Care 2010, 9:36-46.
104. Michel C.E., Sonnex C., Carne C.A., White J.A., Magbanua J.P., Nadala E.C., Lee H.H. Chlamydia trachomatis load at matched anatomical sites: implications for screening strategies. J Clin Microbiol 2007, 45:1395-1402.
105. Chernesky M., Jang D., Portillo E., Chong S., Smieja M., Luinstra K., et al. Abilities of APTIMA, AMPLICOR and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples. J Clin Microbiol 2007, 45:2355-2358.
106. Gaydos C.A., Ferrero D.V., Papp J. Laboratory aspects of screening men for Chlamydia trachomatis in the new millennium. Sex Tansmit Dis 2008, 35(Suppl.):S45-S50.
107. Association of Public Health Laboratories. Guidelines for the laboratory testing of STDs. 2009; [accessed 24.05.12] 1-6. http://www.aphl.org/aphlprograms/infectious/std/Pages/stdtestingguidelin es.aspx.
108. Hsieh Y.-H., Howell M.R., Gaydos J.C., McKee J.K.T., Gaydos C.A. Preference among female army recruits for use of self-administered vaginal swabs or urine to screen for Chlamydia trachomatis genital infections. Sex Trans Dis 2003, 30:769-773.
109. Newman S.B., Nelson M.B., Gaydos C.A., Friedman H.B. Female prisoners' preference of collection methods for testing for Chlamydia trachomatis and Neisseria gonorrhoeae infection. Sex Trans Dis 2003, 30:306-309.
110. Chernesky M.A., Hook E.W., Martin D.H., Lane J., Johnson R., Jordan J.A., et al. Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections. Sex Transmit Dis 2005, 32:729-733.
111. Serlin M., Shafer M.A., Tebb K., Gyamfi A.-A., Moncada J., Schachter J., et al. What sexually transmitted disease screening method does the adolescent prefer? Adolescents' attitudes toward first-void urine, self-collected vaginal swab, and pelvic examination. Arch Pediatr Adoesc Med 2002, 156:588-591.
112. Blake D., Maldeis N., Barnes M.R., Hardick A., Quinn T.C., Gaydos C.A. Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis 2008, 35:649-655.
113. Schachter J., Moncada J., Liska S., Shayevich C., Klausner J.D. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum of men who have sex with men. Sex Tansmit Dis 2008, 35:637-642.
114. Ota K.V., Tamari I.E., Smieja M., Jamieson F., Jones K.E., Towns L., et al. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in pharyngeal and rectal specimens using the BD probetec ET system, the Gen-Probe aptima combo2 assay and culture. Sex Transm Infect 2009, 85:182-186.
115. Berg A.O. Screening for chlamydia infection. Recommendations and rationale. Amer J Prev Med 2001, 20:90-94.
116. Gift T.L., Lincoln T., Tuthill R., Whelan M., Briggs L.P., Conklin T., et al. A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community. Sex Tansmit Dis 2006, (33 Suppl.):S103-S110.
117. Hillis S.D., Coles F.B., Litchfield B., Black C.M., Mojica B., Schmitt K., et al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. Sex Trans Dis 1998, 25:5-11.
118. Jacobson G.F., Autry A.M., Kirby R.S., Liverman E.M., Motley R.U. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. Am J Obstet Gynecol 2001, 184:1352-1354.
119. Kacmar J., Cheh E., Montagno A., Peipert J.F. A randomized trial of azithromycin versus amoxicillin for the treatment of Chlamydia trachomatis in pregnancy. Infect Dis Obstet Gynecol 2001, 9:197-202.
120. Rahangdale L., Guerry S., Bauer H.M., Packel L., Rhew M., Baxter R., et al. An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex Transm Dis 2006, 33:106-110.
121. Gaydos C.A., Wright C., Wood B.J., Waterfield G., Hobson S., Quinn T.C. Chlamydia trachomatis re-infection rates among female adolescents seeking rescreening in school based health centers. Sex Tansmit Dis 2008, 35:233-237.
122. Whittington W.L.H., Kent C., Kissinger P., Oh M.K., Fortenberry J.D., Hillis S.E., et al. Determinants of persistent infection and recurrent Chlamydia trachomatis infection in young women. Sex Trans Dis 2001, 28:117-123.
123. Yu Y., Frazure-Williams J., Duhnn E., Bolan G., Markowitz L., Bauer H. Chlamydia partner services for females in California family planning clinics. Sex Transmit Dis 2011, 38:913-918.
124. Mehta S.D., Rothman R.E., Kelen G.D., Quinn T.C., Zenilman J.M. Unsuspected gonorrhea and chlamydia in patients of an urban adult emergency department. A critical population for STD control. Sex Transmit Dis 2001, 28:33-39.
125. Mehta S.D., Rothman R.E., Kelen G.D., Quinn T.C., Zenilman J.M. Clinical aspects of diagnosis of gonorrhea and chlamydia infection in an acute care setting. Clin Infect Dis 2001, 32:655-659.
126. Finelli L., Schillinger J.A., Wasserheit J.N. Are emergency departments the next frontier for sexually transmitted disease screening?. Sex Trans Dis 2001, 28:40-42.
127. Mertz K.J., Schwebke J.R., Gaydos C.A., Beidinger H.A., Tulloch S.D., Levine W.C. Screening women in jails for chlamydial and gonococcal infection using urine tests: feasibility, acceptability, prevalence, and treatment rates. Sex Transmit Dis 2002, 29:271-276.
128. Asbel L.E., Newbern A.C., Salmon M., Spain C.V., Goldberg M. School-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae among Philadelphia public high school students. Sex Tansmit Dis 2006, 33:614-620.
129. Golden M.R., Whittington W.L.H., Handsfield H.H., Hughes J.P., Stamm W.E., Hogben M., et al. Effect of expediated treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. NEJM 2005, 352:676-685.
130. Schillinger J., Kissinger P., Calvet H., et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transmit Dis 2003, 30:49-56.
131. Kissinger P., Mohammed H., Richardson-Alston G., et al. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis 2005, 41:623-629.
132. Cameron S., Glasier Scott, et al. Novel interventions to reduce re-infection in women with chlamydia: a randomized, controlled trial. Hum Reprod 2009, 24:888-895.
133. Kerns J., Jones H., Pressman E., Fratarelli L., Garth J., Westhoff C. Implementation of expediated partner therapy among women with chlamydia infection at an urban family planning clinic. Sex Transmit Dis 2011, 38:722-726.
134. Joffe A., Reitmeijer C.A., Chung S., Willard N., Chapin J.B., Lloyd L.V., et al. Screening asymptomatic adolescent males for Chlamydia trachomatis in school-based health centers using urine-based nucleic acid amplification tests. Sex Transm Dis 2008, 35(Suppl.):S19-S23.
135. Blake D.R., Quinn T.C., Gaydos C.A. Should asymptomatic males be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program. Sex Tansmit Dis 2008, 35:91-101.
136. Nevin R.L., Shuping E.E., Frick K.D., Gaydos J.C., Gaydos C.A. Cost and effectiveness of chlamydia screening among male military recruits: Markov modeling of complications averted through notification of prior female partners. Sex Tansmit Dis 2008, 35:705-713.
137. Gift T.L., Blake D.R., Gaydos C.A., Marrazzo J.M. The cost-effectivness of screening men for Chlamydia trachomatis: a review of the literature. Sex Tansmit Dis 2008, 35(Suppl.):S51-S60.
138. Howell M.R., McKee J.K.T., Gaydos J.C., Quinn T.C., Gaydos C.A. Point-of-entry screening for C. trachomatis in female army recruits: who derives the cost savings?. Amer J Prev Med 2000, 19:160-166.
139. Hu D., Hook E.W., Goldie S.J. Screening for Chlamydia trachomatis in women 15 to 29 years of age: a cost-effectiveness analysis. Annals of Intern Med 2004, 141:1501-1513.